"Association Between Use of β-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction"
"Conclusions and Relevance In patients with HFPEF, use of β-blockers was associated with lower all-cause mortality but not with combined all-cause mortality or heart failure hospitalization. β-Blockers in HFPEF should be examined in a large randomized clinical trial."
http://jama.jamanetwork.com/article.aspx?articleid=1935124
No comments:
Post a Comment